中基長壽科學(00767.HK)中期扭虧為盈至643.7萬港元
格隆匯8月29日丨中基長壽科學(00767.HK)公吿,截至2022年6月30日止6個月,集團錄得總收益3305.4萬港元。集團於期內錄得耀眼的轉虧為盈,錄得643.7萬港元(截至2021年6月30日止6個月:期內虧損2085.1萬港元)。每股基本及攤薄盈利為0.04港仙(2021年6月30日:每股基本及攤薄虧損為0.14港元)。
借貸及金融諮詢業務錄得靜態收入1510.1萬港元及分部溢利1268.4萬港元。整體而言,長壽科學業務貢獻了1795.3萬港元的收入和698.9萬港元的分部利潤,為公司整體業績提供了緩衝。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.